BELLICUM PHARMACEUTICALS, INC Quarterly Operating Margin in % from Q4 2017 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q3 2023.
  • Bellicum Pharmaceuticals, Inc Operating Margin for the quarter ending September 30, 2023 was -1.58K %.
  • Bellicum Pharmaceuticals, Inc annual Operating Margin for 2022 was -1.8K %, a 348% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Operating Margin for 2021 was -401 %, a 96.1% increase from 2020.
  • Bellicum Pharmaceuticals, Inc annual Operating Margin for 2020 was -10.3K %, a 745% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -1.58K Jul 1, 2023 Sep 30, 2023
Q2 2023 -2K Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.97K Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.8K Oct 1, 2022 Dec 31, 2022
Q4 2020 -10.3K -9.12K -745% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.02K +3.28K +76.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.22K +2.76K +69.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.18K +5.38K +82% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.22K +7.3K +85.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -4.31K +7.65K +64% Jul 1, 2019 Sep 30, 2019
Q2 2019 -3.98K +11.4K +74.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -6.56K +35.2K +84.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -8.52K +38.7K +82% Oct 1, 2018 Dec 31, 2018
Q3 2018 -12K Jul 1, 2018 Sep 30, 2018
Q2 2018 -15.3K Apr 1, 2018 Jun 30, 2018
Q1 2018 -41.7K Jan 1, 2018 Mar 31, 2018
Q4 2017 -47.2K Oct 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.